BlueBox Precision Medicine R UK GBP Acc
Management
| Name of company | BlueBox Asset Management UK Ltd |
| Phone | - |
| Website | - |
| Address | Cayman Islands - - Cayman Islands |
Fund
| Domicile | LUX |
| Legal structure | SICAV |
| UCITS | Yes |
| Inception date | 11/03/2025 |
Managers
| Fund manager | Mark Dainty |
| Manager start date | 28/02/2023 |
| Biography | Mark joined BlueBox in 2022 to launch the BlueBox Precision Medicine Fund. He has been researching and investing in the Healthcare sector since 2006. Prior to BlueBox he was the Lead Portfolio Manager of a pharmaceuticals and biotechnology fund at Norges Bank Investment Management for 6 years. He also spent 3 years at Blackrock as a global healthcare analyst and 6 years at Citi in a leading equity research team covering European pharmaceuticals. He holds a Masters in Pharmacy and became a Chartered Accountant (FCA) with KPMG. This combination is critical for evaluating businesses that create lasting value through innovation in the biopharmaceutical sector. |
| Fund manager | Polina Suter |
| Manager start date | 01/04/2025 |
| Biography | Polina Suter holds a PhD in Computational Biology and a Master’s in Statistics from ETH Zurich, where her research focused on data science applied to precision oncology. She began her career as a Portfolio Manager at UFG Asset Management, specializing in hedging and derivatives strategies, and later managed a proprietary biotech portfolio at Principal Partners, a family office. Most recently, she worked as a Data Scientist at LifeMine Therapeutics, where her interdisciplinary role included applying computational methods to translational medicine and analytical chemistry in the context of early-stage drug discovery. |